Otsuka’s ADHD drug centanafadine is currently under review by the US FDA, with a PDUFA date of 24 July 2026.

Although originally developed as an antidepressant, long-term bupropion (BUP) treatment was recently shown to cause 5–8% weight loss over placebo in clinical trials with obese adults. BUP's ...

Patients with depression benefit from taking venlafaxine and duloxetine, two drugs belonging to the selective serotonin and norepinephrine reuptake inhibitor drug class. This is the conclusion of a ...

Predictive model of response to epoetin-alfa in anemic patients with solid tumors receiving chemotherapy: Results from a multicenter prospective study No significant financial relationships to ...

Several medication options may help manage symptoms of post-traumatic stress disorder (PTSD). These include SSRIs (selective serotonin reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake ...

The risk of serotonin syndrome in patients prescribed both triptans for migraine and antidepressants appears to be low, which may suggest an advisory from the US Food and Administration on that risk ...